Cutaneous manifestations of connective tissue disease

There is evidence that early treatment of connective tissue in adolescence improves clinical outcomes; thus, recognition of the cutaneous manifestation of CTD is critical. This review summarizes the clinical features that are unique to children and adolescents in cutaneous (CLE) and systemic lupus e...

Full description

Saved in:

Bibliographic Details
Published in:	Adolescent medicine (Elk Grove Village, Ill.) Vol. 22; no. 1; p. 35
Main Authors:	McCammack, Erin, Haggstrom, Anita N
Format:	Journal Article
Language:	English
Published:	United States 01-04-2011
Subjects:	Adolescent Antirheumatic Agents - therapeutic use Connective Tissue Diseases - drug therapy Connective Tissue Diseases - physiopathology Glucocorticoids - therapeutic use Humans Hydroxychloroquine - therapeutic use Immunosuppressive Agents - therapeutic use Lupus Erythematosus, Cutaneous - drug therapy Lupus Erythematosus, Cutaneous - physiopathology Lupus Erythematosus, Discoid - drug therapy Lupus Erythematosus, Discoid - physiopathology
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	There is evidence that early treatment of connective tissue in adolescence improves clinical outcomes; thus, recognition of the cutaneous manifestation of CTD is critical. This review summarizes the clinical features that are unique to children and adolescents in cutaneous (CLE) and systemic lupus erythematosus (SLE), juvenile dermatomyositis (JDM), juvenile systemic scleroderma (JSS), juvenile localized scleroderma (JLS), and juvenile inflammatory arthritis (JIA).
ISSN:	1934-4287